Abstract

A Convergent Synthetic Platform for Nanoparticle with Combination against Visceral Leishmaniasis

The synthesis of PLGA-Nanoparticles therapeutics capable of controlled loading and synchronized release of multiple therapeutic agents remains a difficult challenge in drug delivery and polymer chemistry. Herein, we report the synthesis of PLGA-Nanoparticles that carry accurate weight ratios of Amphotericin B and Doxorubicin. To our knowledge, this work provides the example of macrophage targeted therapy against visceral leishmaniasis by incorporating macrophage specific ligand-Lectin which specifically targets to the localized target sites. The highly convergent synthetic approach opens the door to new Nanoparticles based combination therapies for visceral leishmaniasis.


Author(s):

Prachi Sharma and Swati Gupta



Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+

Recommended Conferences

  • International Conference on Drug Discovery, Designing and Development
    June 27-28, 2018 Vancouver, British Columbia, Canada
  • World Drug Delivery Summit
    September 24-25, 2018 (10 Plenary Forums - 1Event) Chicago, Illinois, USA
  • International Conference on Pharmaceutical Chemistry
    October 29-31, 2018 Brussels, Belgium
Flyer image

Abstracted/Indexed in

  • Chemical Abstracts Service (CAS)
  • Index Copernicus
  • Google Scholar
  • Genamics JournalSeek
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • WorldCat
  • Publons
  • MIAR
  • ResearchGate
  • University Grants Commission